Giant cutaneous squamous cell carcinoma of the scalp arising in the setting of folliculitis decalvans

  1. Liang Ding 1,
  2. Jason C DeGiovanni 2,
  3. Paul Bogner 3 and
  4. Yousef Soofi 1
  1. 1 Department of Pathology, State University of New York at Buffalo, Buffalo, New York, USA
  2. 2 Department of Otolaryngology – Head and Neck Surgery, State University of New York at Buffalo, Buffalo, New York, USA
  3. 3 Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA
  1. Correspondence to Dr Liang Ding; liangdin@buffalo.edu

Publication history

Accepted:11 Feb 2022
First published:08 Mar 2022
Online issue publication:08 Mar 2022

Case reports

Case reports are not necessarily evidence-based in the same way that the other content on BMJ Best Practice is. They should not be relied on to guide clinical practice. Please check the date of publication.

Abstract

Squamous cell carcinoma (SCC) is uncommon in African Americans (AAs), with an incidence of approximately 0.003%. However, it is the most common skin cancer in that patient population. In AAs, SCC typically arises in sun-protected areas and mainly affects patients older than 50 years. We report a case of giant SCC in an AA man in his 40s with long-standing folliculitis decalvans on the scalp. Three previous skin biopsies were inconclusive. A wide excision was performed and the defect was reconstructed with an anterolateral thigh free flap. Histological analysis of the resected specimen revealed a well-moderately differentiated keratinising SCC with clear cell changes, severe mixed inflammation, folliculitis and dermal scar. He was discharged 2 weeks later and has been followed up closely. Four months later, the patient presents with metastatic SCC to an occipital lymph node.

Background

Skin cancer is the most common malignancy in the United States and accounts for 40% of all cancers in Caucasians and 1%–5% in people of colour.1 More specifically, skin cancer accounts for 1%–2% of all cancers in African Americans (AAs).2 Among all skin cancers, squamous cell carcinoma (SCC) is the most common skin cancer in AAs, with an incidence of approximately 3 per 100 000, and the second most common type in Caucasians, Hispanics and Asians.2 Overall, SCC accounts for about 75% of all deaths caused by non-melanoma skin cancers in the general population.3 SCC primarily affects older patients, typically over the age of 50. The incidence of SCC in patients younger than 40 years is 3.9 per 100 000.4 In Caucasians, SCC usually develops in sun-exposed areas, while in AAs, SCC often develops in sun-protected areas such as the lower limbs and anogenital region.2 It is well known that ultraviolet (UV)-radiation-induced mutations in N-RAS and p53-related genes play a central role in the pathogenesis of SCC in light-complexioned skin.5 The increased epidermal melanin in dark skin protects from chronic UV radiation, resulting in a low incidence of SCC in AAs. Chronic inflammation and scaring are more significant risk factors for SCC in dark skin.6 SCCs larger than 10 cm in all races are rare, and few cases have been reported. Due to the low incidence, published data of SCC, especially giant SCC, in the AA population is minimal.

Case presentation

We report an AA man in his 40s who presented with a giant SCC (greater than 10 cm). He had a long-standing history of folliculitis decalvans (chronic cicatricial alopecia), clinically presenting as atrophic hyperpigmented plaques on the scalp. No medical history or family history of neoplasm was reported. Previously, the patient noted enlargement of plaques on the right posterior scalp that grew into cutaneous horns with occasional itching. He visited the dermatologist, and a shave biopsy showed skin with extensive dermal scarring, mixed inflammation, follicular plugging and rupture, extravasated hair shafts, and features consistent with folliculitis decalvans. A punch biopsy was performed in the following years, and showed histology similar to the previous shave biopsy. Special stains were negative for microorganisms, including spirochetes. Several months prior to his diagnosis of SCC, the patient noted that the cutaneous horns on his scalp grew into an 11 × 10 × 5 cm exophytic, verrucous-like mass.

Investigations

A skin biopsy of the new mass showed features of pseudoepitheliomatous hyperplasia with severe inflammation and some concerning cytological atypia and architectural complexity. Based on the biopsy, confident exclusion of a heavily inflamed carcinoma was not possible. A concurrent microbiology analysis of the scalp revealed heavy growth of Pseudomonas aeruginosa.

Since the skin biopsies were inconclusive, the patient was scheduled for surgical resection of the lesion. A preoperative head CT scan demonstrated a bulky soft tissue mass extending across the midline, the left parietal scalp and the right posterior subgaleal soft tissue. No distinct areas of osseous erosion or destruction are present (figure 1A,B). The patient underwent mass resection with minimal 2 cm negative margins confirmed by frozen sections.

Figure 1

A giant mass on the scalp. Head CT shows tumour extension and non-involvement of the skull: sagittal (A) and axial view (B). (C) The exophytic, verrucous-like mass measures 11 × 10 × 5 cm. (D,E) Serial sectioning of the mass reveals a tan, lobulated cut surface, with the invasion of the subcutaneous tissue. Scale = 2 cm.

The oriented specimen was received fresh, and as shown in figure 1C, revealing a tan, firm, exophytic mass with a lobulated surface. Serial sectioning of the mass revealed invasion of the subcutaneous tissue and negative margins (figure 1D,E). The histological evaluation showed moderately differentiated keratinising SCC with clear cell changes in a background of severe acute and chronic inflammation (figure 2A,B), folliculitis (figure 2C) and scarring alopecia (figure 2D). The tumour was measured to be 4.1 cm with subcutaneous invasion but lymphovascular invasion noted.

Figure 2

Well-moderately differentiated squamous cell carcinoma (SCC). SCC shows a verrucous configuration (A), clear cell change, invasion, and severe acute and chronic inflammation (B). (C) Folliculitis including follicular destruction, naked hair shaft, foreign body type giant cells, lymphoplasmacytic and neutrophilic infiltrate. (D) Areas of scarring alopecia with perifollicular fibrosis (arrow) and dermal fibrosis.

Differential diagnosis

The differential diagnosis was primarily between SCC and pseudoepitheliomatous hyperplasia. Pseudoepitheliomatous hyperplasia can occur secondary to underlying infection or another tumour type (lymphoma, granular cell tumour, etc).

Treatment

The patient received reconstruction of his scalp defect with a right anterolateral thigh free flap. Given the size of the defect after resection, this was the only reconstructive option that was suitable. The postoperative course was notable for a haematoma, which was evacuated promptly, but was otherwise uneventful. The patient was ultimately discharged 2 weeks after his initial surgery. He did not receive any adjuvant therapies, as these were not warranted.

Outcome and follow-up

The patient was followed up by the head and neck surgery department. He cleaned the surgical wound at home and received oral antibiotics. The wound healed well, and the patient had no specific complaints. However, occipital lymphadenopathy was noted during a follow-up visit 4 months after surgery. A CT shows an enlarged lymph node. The lymph node’s fine needle aspiration and subsequent cytological evaluation revealed metastatic SCC (figure 3).

Figure 3

CT scan and fine needle aspiration (FNA) of the lymph node were performed 4 months after the surgery. (A) The clinical course timeline is summarised here. (B) Head CT reveals an enlarged lymph node (arrow) in the occipital area. (C) Cytological analysis with Papanicolaou staining shows keratinising (red-orange) and non-keratinising neoplastic squamous cells. Pathological mitosis is shown in the insert. (D) The cell block prepared from FNA material shows keratins and neoplastic squamous cells (arrow, H&E staining). SCC, squamous cell carcinoma.

Discussion

The most common site of SCC in AAs is sun-protected areas such as the legs. Our patient developed SCC in the scalp, a tumour site more commonly seen in Caucasian patients. However, instead of UV radiation damage, the primary aetiology in this case is presumptively chronic inflammation and the scarring process. Chronic scarring and inflammation are among the most critical risk factors for SCC development in AAs, in scenarios such as Marjolin’s ulcer, discoid lupus erythematosus and hidradenitis suppurativa.7–10

Folliculitis decalvans is a rare, chronic scarring alopecia of unknown aetiology. It typically appears as an expanding alopecia patch with peripheral pustules on the scalp of adults. Based on a large retrospective study, the estimated incidence is 3% of all alopecia and 11% of all cicatricial alopecia, with a male predominance.11 Histopathologically, early lesions show perifollicular neutrophilic infiltrates that develop into destructive, suppurative folliculitis.12 The late lesions show perifollicular fibrosis, follicular tufting and dermal fibrosis.12 Usually, after treatment, 87% of folliculitis decalvans patients achieve remission or disease control. So far, only two cases of SCC arising within folliculitis decalvans have been reported, and the tumours measured 8 mm and 2.5 cm, respectively.13 14 To our knowledge, a giant SCC arising within folliculitis decalvans on the scalp of a young AA has not been reported before.

Giant SCC greater than 10 cm is rare. The delay in diagnosis is multifactorial, involving a confluence of socioeconomic, environmental, psychological and physical factors.15 SCCs arising within chronic inflammatory lesions have been associated with a delay of clinic visits greater than 9 months.15 In our case, the tumour was neglected for about 2 years and grew into a giant mass.

Risk factors for SCC metastasis include increased tumour size (greater than 2 cm), poor differentiation, invasion depth greater than 4–8 mm and certain histological features (acantholysis, single-cell invasion, small tumour nests and infiltrating strands).16 SCC arising in chronic inflammation and scarring processes is more prone to metastasise than those related to sun exposure.9 In the current case, tumour size, background chronic inflammation/scarring and infiltrative growth strands are high-risk factors for metastasis. However, the SCC was well-moderately differentiated without skull bone involvement, and no other high-risk factors were noted. Therefore, close follow-up after wide excision is warranted.

Adequate sampling is key to making a correct diagnosis. The patient had three skin biopsies (shaves and punches), all of which were diagnostically inconclusive. This was mainly due to inadequate sampling. A punch biopsy samples up to 10 mm (in thickness), and a shave biopsy samples an even more shallow portion of the skin. Insufficient sampling can make it impossible to differentiate well-moderately differentiated keratinising SCC from heavy inflammation-induced reactive changes.

Learning points

  • This is a rare case of a giant SCC in a young African American man in a background of long-standing folliculitis decalvans related to inflammation and chronic scarring.

  • Giant SCC arising in chronic inflammation/scarring process is strongly associated with a poor prognosis. Early diagnosis, treatment and close follow-up are critical.

  • Adequate sampling is pivotal to establishing an accurate diagnosis. A punch biopsy is an up to 10 mm thick skin plug, and the shave biopsy is a portion of the skin, not full thickness. We need to be aware that biopsies may cause inadequate sampling, especially when the cutaneous neoplasms have a large volume.

Ethics statements

Patient consent for publication

Acknowledgments

We want to thank Dr Christopher D’angelis (VA Western New York Healthcare System) for providing a factual review and helping edit the manuscript.

Footnotes

  • Contributors YS was the pathologist who received the resection specimen, made the final diagnosis and directed this case report. LD was the pathology resident who participated in the specimen examination and diagnosis, drafted the manuscript and designed the figures. JD was the otolaryngology resident who participated in the surgery, patient follow-ups, manuscript modification and obtaining patient consent. PB was involved in the clinical management of the patient in the past. He reviewed the patient’s biopsy slides and edited the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

References

Use of this content is subject to our disclaimer